UnitedHealth Group (NYSE:UNH) Removed From Multiple Russell Growth Indexes

On June 30, 2025, UnitedHealth Group (NYSE:UNH) faced a significant repositioning as it was removed from multiple growth indices, including the Russell Top 200 Growth Index, indicating a shift in its investor perception as a growth stock. Over the past month, UnitedHealth's share price increased by 2%, aligning closely with broader market gains amid a favorable environment for U.S. stocks, seen through record highs in major indices like the S&P 500 and the Nasdaq Composite. Despite the pressure from index removals, UnitedHealth's dividend increase and completed debt financing likely supported investor sentiment.

UnitedHealth Group has 1 warning sign we think you should know about.

The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 23 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.

The recent shifts in UnitedHealth Group's standing, such as its removal from growth indices, may significantly impact the narrative of its strategic refocus. As UnitedHealth adjusts its Medicare strategies and invests in technology, these changes could stabilize and potentially enhance revenue and earnings forecasts. Despite losing status as a growth stock, the company's initiatives in value-based care and predictive models might cushion this transition. The index exclusion could also affect investor sentiment, though the company's dividend increase and completed debt financing appear to support short-term confidence.

Looking at longer-term performance, UnitedHealth's shares delivered a total return of 11.84% over the five years leading up to June 2025. This return reflects both share price appreciation and dividends, providing context for investors assessing the company's recent developments. Over the past year, while UnitedHealth underperformed the US market's 13.7% return, its returns were higher than the US Healthcare industry's negative return of 18.1%.

Explore UnitedHealth Group's analyst forecasts in our growth report.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com